Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-05-24 @ 1:02 PM
Study NCT ID:
NCT03463460
Status:
RECRUITING
Last Update Posted:
2025-08-24
First Post:
2018-02-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab and Sunitinib Malate in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
Sponsor:
Dwight Owen
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSU-17234
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |